Connection
Daniel Bowles to Response Evaluation Criteria in Solid Tumors
This is a "connection" page, showing publications Daniel Bowles has written about Response Evaluation Criteria in Solid Tumors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.124 |
|
|
|
-
Bowles DW, Senzer N, Hausman D, Peterson S, Vo A, Walker L, Cohen RB, Jimeno A. A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck. Invest New Drugs. 2014 Dec; 32(6):1197-203.
Score: 0.124